6:37 PM
 | 
Jan 10, 2014
 |  BC Extra  |  Top Story

FDA reviewer recs complete response for Northera

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) fell $1.03 (29%) to $2.50 on Friday after an FDA...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >